Mandate

Vinge advises Capio in connection with acquisition of Backa Läkarhus

January 05, 2017

The operations had a turnover of approximately MSEK 345 in 2016, and have 83 000 listed patients. Closing is subject to customary closing conditions from the relevant county councils and unconditional approval from the Swedish Competition Authority. The enterprise value amounts to MSEK 300.

Vinge’s team primarily consists of client responsible partner Anders Strid, Frida Bäckegren (project leader M&A), Lina André and Jonas Lindblad (employment), Gabriella Fossum (procurement), Mercedes Anderås (real estate), Camilla Andersson (corporate) as well as Pär Remnelid, among others (competition).

Related

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026

Vinge has advised Skeptiva AB in connection with its financing round

Skeptiva is developing the next generation of cybersecurity defenses against fraud. The company has developed an AI application that detects attacks and alerts users in real time.
March 11, 2026

Vinge has advised Main Capital in connection with the acquisition of Good Solutions Sweden AB

Good Solutions Sweden AB (”Good Solutions”) provides software that helps factories identify and reduce production losses. The software converts data from machines and operators into insights that can be used to streamline production and increase profitability.
March 11, 2026